SynthesisJCO precision oncology2022

Clinical Utility of CDK4/6 Inhibitors in Sarcoma: Successes and Future Challenges.

Jocelyn Y Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.